A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
benzingaš Article Content
Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers SquibbBMY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BMY usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Bristol-Myers Squibb. This level of activity is out of the ordinary.The general mood among these heavyweight investors is divided, with 33% leaning bullish and 66% bearish. Among these notable options, 3 are puts, totaling $202,924, and 6 are calls, amounting to $320,715.Trending Investment OpportunitiesAdvertisementArrivedBuy shares of homes and vacation rentals for as little as $100.Get StartedWiserAdvisorGet matched with a trusted, local financial advisor for free.Get StartedPoint.comTap into your home's equity to consolidate debt or fund a renovation.Get StartedRobinhoodMove your 401k to Robinhood and get a 3% match on deposits.Get StartedProjected Price TargetsAfter evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $46.0 and $50.0 for Bristol-Myers Squibb, spanning the last three months.Volume & Open Interest DevelopmentExamining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Bristol-Myers Squibb's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Bristol-Myers Squibb's significant trades, within a strike price range of $46.0 to $50.0, over the past month.Bristol-Myers Squibb 30-Day Option Volume & Interest SnapshotBiggest Options Spotted:SymbolPUT/CALLTrade TypeSentimentExp. DateAskBidPriceStrike PriceTotal Trade PriceOpen InterestVolumeBMYPUTSWEEPBEARISH12/19/25$3.55$3.5$3.55$46.00$150.9K175426BMYCALLTRADEBEARISH01/16/26$3.05$2.87$2.9$50.00$130.7K6.7K500BMYCALLTRADEBEARISH08/29/25$1.31$1.2$1.2$49.00$54.0K6450BMYCALLSWEEPBEARISH09/19/25$1.37$1.35$1.35$50.00$37.6K6.7K342BMYCALLSWEEPBULLISH09/19/25$2.51$2.44$2.51$48.00$37.6K656150About Bristol-Myers SquibbBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.In light of the recent options history for Bristol-Myers Squibb, it's now appropriate to focus on the company itself. We aim to explore its current performance.Where Is Bristol-Myers Squibb Standing Right Now?Currently trading with a volume of 5,984,142, the BMY's price is down by -0.19%, now at $47.25.RSI readings suggest the stock is currently is currently neutral between overbought and oversold.Anticipated earnings release is in 16 days.Expert Opinions on Bristol-Myers SquibbOver the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $34.0.Unusual Options Activity Detected: Smart Money on the MoveBenzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks.Click here for access. * An analyst from Morgan Stanley persists with their Underweight rating on Bristol-Myers Squibb, maintaining a target price of $34.Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bristol-Myers Squibb options trades with real-time alerts fromBenzinga Pro.BMYBristol-Myers Squibb Co$46.30-2.20%Stock Score Locked: Want to See it?Benzinga Rankings give you vital metrics on any stock ā anytime.Reveal Full ScoreEdge RankingsMomentum45.01Growth65.70QualityN/AValue32.30Price TrendShortMediumLongOverviewMarket News and Data brought to you by Benzinga APIsĀ© 2025 Benzinga.com. . .EarningsAnalyst RatingsOptionsDividendsIPOsDate of Tradeā²ā¼tickerā²ā¼Put/Callā²ā¼Strike Priceā²ā¼DTEā²ā¼Sentimentā²ā¼Click to see moreOptionsupdatesOptions ActivityIdentify Smart Money MovesSee what positions smart money is taking on your favorite stocks with the Benzinga Edge Unusual Options board.Click to JoinPosted In:OptionsMarketsBZI-UOA